Open access
Aug 2026
Adjuvant chemotherapy patterns and clinicopathological factors associated with survival in patients aged 70 years and older with resected stage II–III colon cancer: a single-center real-world study
Aims: Older adults are underrepresented in adjuvant colon cancer trials, leaving uncertainty regarding oxaliplatin benefit and optimal treatment duration. This study evaluated the associations of adjuvant chemotherapy patterns, treatment duration, and clinicopathological factors with overall survival (OS) and disease-f...
Zekeriya Hannarici, A. Turhan, M. E. Büyükbayram et al.
· Journal of Medicine and Pall... · 0 citations